 NEW YORK, March 07, 2022 GLOBE NEWSWIRE -- GBS Nasdaq: GBS, a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that Dr. Steven Boyages, GBS interim CEO and Chairman of the Board, along with other management team members will participate in the following conferences in March and invites investors to participate in one-on-one meetings. Please see additional details below: 